Safety and efficacy of bivalirudin with and without glycoprotein IIb/IIIa inhibitors in patients with acute coronary syndromes undergoing percutaneous coronary intervention 1-year results from the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial. [electronic resource]
Producer: 20080919Description: 807-14 p. digitalISSN:- 1558-3597
- Acute Coronary Syndrome -- drug therapy
- Adult
- Aged
- Aged, 80 and over
- Angioplasty, Balloon, Coronary
- Anticoagulants -- adverse effects
- Drug Therapy, Combination
- Enoxaparin -- adverse effects
- Female
- Fibrinolytic Agents -- adverse effects
- Heparin -- adverse effects
- Hirudins -- adverse effects
- Humans
- Male
- Middle Aged
- Peptide Fragments -- adverse effects
- Platelet Glycoprotein GPIIb-IIIa Complex -- antagonists & inhibitors
- Recombinant Proteins -- adverse effects
- Risk Factors
- Time Factors
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.